Spending the day, as I often do, listening to company conference presentations and/or–in today’s case, and–meetings with management teams. Today, I’m in drug world (no, not the way you might think).
So what’cha got? Some interesting sidelights on drug pricing from a conference presentation this morning, given by a company, Neurocrine